alexa Statins and risk of cancer: a systematic review and metaanalysis.
Reproductive Medicine

Reproductive Medicine

Andrology-Open Access

Author(s): Browning DR, Martin RM

Abstract Share this page

Abstract We conducted a systematic review of the association between HMG-CoA reductase inhibitor (statin) use and cancer risk. We searched MEDLINE, EMBASE, Web of Science, ISI Proceedings and BIOSIS Previews bibliographic databases, electronic trials registers and reference lists for potentially eligible randomized trials and observational studies. Thirty-eight individual studies (26 randomized trials involving 103,573 participants and 12 observational studies with 826,854 participants) were included. Median follow-up was 3.6 and 6.2 years for trials and observational studies, respectively. In metaanalyses of randomized trials, there was no evidence that statin therapy was associated with incidence of all-cancers (26 trials; pooled risk ratio = 1.00; 95\% CI 0.95-1.05; I(2) = 0\%) or the following site-specific cancers: breast (7 trials; risk ratio = 1.01; 0.79-1.30; I(2) = 43\%), prostate (4 trials; risk ratio = 1.00; 0.85-1.17; I(2) = 0\%), colorectum (9 trials; risk ratio = 1.02; 0.89-1.16; I(2) = 0\%), lung (9 trials; risk ratio = 0.96; 0.84-1.09; I(2) = 0\%), genito-urinary (5 trials; risk ratio = 0.95; 0.83-1.09; I(2) = 0\%), melanoma (4 trials; risk ratio = 0.86; 0.62-1.20; I(2) = 17\%) or gastric (1 trial; risk ratio = 1.00; 0.35-2.85). There was no evidence of differential effects by length of follow-up, statin type (lipophilic vs. lipophobic) or potency. Trial results were generally consistent with observational studies. We conclude that statin use is not associated with short-term cancer risk, but longer-latency effects remain possible. This article was published in Int J Cancer and referenced in Andrology-Open Access

Relevant Expert PPTs

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords